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ABSTRACT
Objective To define early presenting features of bacterial 
meningitis in young infants in England and to review the 
adequacy of individual case management as compared 
with relevant national guidelines and an expert panel 
review.
Design Retrospective medical case note review and 
parental recall using standardised questionnaires.
Setting England and Wales.
Participants Infants aged <90 days with bacterial 
meningitis diagnosed between July 2010 and July 2013.
Results Of the 97 cases recruited across England and 
Wales, 66 (68%) were admitted from home and 31 
(32%) were in hospital prior to disease onset. Almost all 
symptoms reported by parents appeared at the onset 
of the illness, with very few new symptoms appearing 
subsequently. Overall, 20/66 (30%) infants were assessed 
to have received inappropriate prehospital management. 
The median time from onset of first symptoms to first help 
was 5 hours (IQR: 2–12) and from triage to receipt of first 
antibiotic dose was 2.0 hours (IQR: 1.0–3.3), significantly 
shorter in infants with fever or seizures at presentation 
compared with those without (1.7 (IQR: 1.0–3.0) vs 4.2 
(IQR: 1.8–6.3) hours, p=0.02). Overall, 26 (39%) infants 
had a poor outcome in terms of death or neurological 
complication; seizures at presentation was the only 
significant independent risk factor (OR, 7.9; 95% CI 2.3 
to 207.0). For cases in hospital already, the median 
time from onset to first dose of antibiotics was 2.6 (IQR: 
1.3–9.8) hours, and 12/31 (39%) of infants had serious 
neurological sequelae at hospital discharge. Hearing test 
was not performed in 23% and when performed delayed 
by ≥4 weeks in 41%.
Conclusions In young infants, the non-specific features 
associated with bacterial meningitis appear to show no 
progression from onset to admission, whereas there 
were small but significant differences in the proportion of 
infants with more specific symptoms at hospital admission 
compared with at the onset of the illness, highlighting the 
difficulties in early recognition by parents and healthcare 
professionals alike. A substantial proportion of infants 
received inappropriate prehospital and posthospital 
management. We propose a targeted campaign for 
education and harmonisation of practice with evidence-
based management algorithms.
InTRODuCTIOn
Bacterial meningitis in young infants remains 
a significant cause of mortality and long-term 
morbidity.1 During 2010–2011, we conducted 
national, prospective, population-based 
surveillance of bacterial meningitis in infants 
younger than 3 months of age in the UK and 
Ireland and found that 26% of 329 infants 
had poor outcomes at discharge.2 Among 
survivors of neonatal meningitis in the 1980s, 
50% had neurological sequelae at 5 years 
of age,3 and similar rates (40%) have been 
reported in survivors of neonatal bacterial 
meningitis in the 1990s4.
The pathogens responsible for bacterial 
meningitis in young infants are different 
from those causing meningitis in other age 
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Research
Strengths and limitations of this study
 ► The strength of this study lies in the detailed analysis 
of a large cohort of geographically representative 
young infants with bacterial meningitis; this is the 
first study of its kind in the UK.
 ► We did not find any significant differences between 
the recruited and non-recruited cases in relation to 
age, sex, region of the country and causal bacteria 
(data not shown).
 ► Because we relied on paediatricians using their 
discretion to contact parents, however, this may have 
led to exclusion of families of infants who died or 
developed severe sequelae where the paediatrician 
was reluctant to contact the family about the study.
 ► Conversely, some parents may have agreed to 
participate simply because they were concerned 
about their child’s long-term outlook or about 
suboptimal healthcare.
 ► Another potential limitation is that we relied on 
parents’ recall for onset and progression of early 
clinical features. There is, however, evidence from 
other serious infections such as meningococcal 
disease that parents are able to accurately recall in 
detail such life-changing events.
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Table 1 Definitions
Group Definition
Eligible infants Infants <90 days of age in whom a bacterium was isolated from the cerebrospinal 
fluid (CSF), or where a significant bacterial pathogen was isolated from blood 
together with CSF pleocytosis (defined as ≥20 cells/mm3 for infants 0–28 days of 
age and ≥10 cells/mm3 for infants 29–89 days of age)11–13
Age at diagnosis Early onset (0–6 days) and late onset (7–89 days)
Home admission Infants admitted to hospital from home
Inpatients Infants already in hospital at the time, either in the neonatal unit, birthing centre or 
postnatal ward
Time from onset to first help The time from when parents noticed the first clinical feature to the time they 
sought any type of help (phone call or visit)
Time from onset to first dose of antibiotics The time from appearance of first clinical feature to first dose of antibiotics
Time from triage to first dose of antibiotics The time from when infant was triaged by a nurse to the time of administration of 
the first dose of antibiotics
‘In hours’ (www.hscic.gov.uk) Triage in hospital between the hours of 09:00 and 18:00
Appropriateness Advice given prior to admission was judged as appropriate or inappropriate; 
choice of empiric antibiotics and duration of antibiotics were appropriate if in 
conformity with existing guidelines; for example, the use of any antibiotics other 
than amoxicillin and cefotaxime/ceftriaxone in any infant admitted from home 
would be classified as inappropriate
groups,5 with group B streptococci and Escherichia coli 
responsible for more than half the cases; neither are 
currently vaccine-preventable.1
It is recognised that the early presentations of menin-
gitis in young infants can be subtle and non-specific. This 
poses a substantial challenge for parents and healthcare 
workers. In our national surveillance, for example, half 
the infants with bacterial meningitis did not have fever 
at presentation and only 5% had the classic triad of fever, 
bulging fontanelle and seizures.2
Studies of invasive meningococcal disease have 
been able to delineate the onset of specific symptoms 
and signs and chart their progression over the course 
of the illness.6 This information has helped improve 
knowledge and increase awareness of meningococcal 
infections among parents and healthcare workers 
(http://www. meningitis. org/ health- professionals/ 
doctors- in- training). Early recognition of meningo-
coccal infection coupled with rapid antibiotic treatment 
and more aggressive management of children with sepsis 
has subsequently led to improved outcomes.7–9 In adults 
with sepsis, earlier antibiotics have been associated with 
higher survival rates,10 but in infants the evidence base 
is poor even though they have the highest incidence of 
bacterial meningitis.5
We hypothesised that earlier recognition may lead to 
earlier healthcare interventions, which in turn might 
improve the outcomes of bacterial meningitis in young 
infants. We, therefore, undertook a detailed assessment 
of the timing, course and progression of bacterial menin-
gitis in young infants across England and Wales. We also 
compared their initial and subsequent clinical manage-
ment with relevant national guidelines.
MeThODS
We undertook a detailed review of the clinical presenta-
tion and management of bacterial meningitis in young 
infants in England and Wales diagnosed between July 
2010 and July 2013 from the perspectives of parents and 
healthcare workers. We aimed to recruit 100 eligible 
infants (table 1).11–13 Cases were identified from LabBase2 
(a national surveillance database used by National Health 
Service (NHS) hospitals laboratories to voluntarily, elec-
tronically report clinically significant infections to Public 
Health England).14
A study pack containing study details, a consent form 
and a questionnaire was sent to the local paediatrician to 
forward to parents. If families did not respond, we asked 
the paediatrician to send a second pack. Parents of all 
participants completed a questionnaire with details about 
onset and progression of specific symptoms. Participating 
parents also gave informed written consent for the study 
investigators to access their infants’ medical records. All 
stages of care, including prehospital management, initial 
hospital assessment, ongoing care and postadmission 
follow-up, were assessed through an in-depth review of 
hospital notes.
Assessment of management: expert panel and national 
guidelines
An expert panel consisting of a general paediatrician, 
neonatologist, paediatric infectious diseases consultant 
and a paediatric specialist registrar reviewed the data to 
determine appropriateness of prehospital management, 
delays in recognition, empiric antibiotics, antibiotic dura-
tion and follow-up. These were judged according to any 
national guidelines available at the time. The National 
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Figure 1 Recruitment algorithm (*died (8), moved away (5), 
foster care (2), language barrier (2)). Recruited cases were 
from 2010 (n=25), 2011 (n=39), 2012 (n=22) and 2013 (n=11).
Table 2A Basic demographics of parents
Parameter Mother Father
Median parental age (IQR) 29 (26–33) 32 (26–36)
Parents’ highest academic level: 
mothers (n=79), fathers (n=77) 
  Postgraduate 16 (20%) 7 (9%)
  Graduate 16 (20%) 15 (19%)
  A levels 20 (25%) 13 (17%)
   (GCSEs) 27 (34%) 42 (55%) 
Parents’ accommodation: 
mothers (n=87), fathers (n=77)
  Own house/flat 45 (52%) 45 (58%) 
  Rented house/flat 35 (40%) 26 (34%)
  Council house/flat 7 (8%) 6 (8%)
GCSEs, General Certificate of Secondary Education; PICU, 
paediatric intensive care unit.
Institute for Health and Care Excellence (NICE) feverish 
illness in children aged <5 years guideline15 was used 
to assess the appropriateness of advice/actions prior to 
hospital admission in febrile infants; in the absence of 
fever, the expert panel proposed a standard best practice. 
The Bacterial Meningitis and Meningococcal Septi-
caemia in Children guideline16 was used to assess the 
appropriateness of empiric antibiotics, length of treat-
ment and timing of audiology testing for all cases. The 
management of infants presenting in the first 72 hours 
of life was assessed against the NICE antibiotics for early-
onset neonatal infection guideline.17 We adhered to the 
Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) guidelines for reporting obser-
vational studies.
Data collection
Parents completed a questionnaire, which recorded the 
time of first appearance and progression of predefined 
clinical features. Information on any illnesses in the 
previous 2 weeks was also requested. Hospital medical 
notes and general practitioner (GP) letters in the medical 
notes were used to corroborate parental recollection of 
onset, timing and progression of events.
Data analysis
The data are mainly descriptive. We plotted the appear-
ance and course of symptoms from the time of onset of 
first symptoms. The timing of each subsequent feature 
was then recorded and rounded to the nearest hour. For 
children admitted from home, we calculated the number 
of hours from the onset of illness to seeking any medical 
help (‘first help’=hospital attendance, GP attendance or 
phone contact with a health professional) and to hospital 
admission. We compared the prevalence of symptoms at 
onset and at hospital presentation (infants admitted from 
home) or at diagnosis (inpatients). We also compared 
presenting features and clinical management in infants 
admitted from home and inpatients. Continuous data 
that did not follow a normal distribution are described as 
medians with IQRs and compared using the Mann-Whitney 
U or Kruskal-Wallis test, as appropriate. Proportions were 
compared using Χ2 or Fisher’s exact test, as appropriate. 
To identify independent risk factors for poor outcomes 
(death or serious complications), potential explanatory 
factors were included in a backward, stepwise multivari-
able logistic regression model, and the least significant 
parameter was then sequentially removed until only those 
parameters with p<0.05 remained.
ReSulTS
A total of 224 infants with bacterial meningitis were iden-
tified and study information forwarded to the parents 
(figure 1). The parents of 103 infants (46%) agreed to 
participate, but six cases were subsequently excluded 
because they did not meet the inclusion criteria. Demo-
graphic data on parents and infants are shown in 
table 2A,B. Cases were recruited from 48 hospitals repre-
senting all English regions (table 2B). Sixty-six (68%) 
infants were at home when they became unwell and 
31 (32%) were inpatients. Most parents (92/97, 95%) 
completed the study questionnaire. The median time 
(IQR) from diagnosis to return of questionnaire was 286 
days (84–252).
Cases admitted from home (n=66)
The median age at diagnosis of bacterial meningitis was 
14 days (IQR: 3–25), higher in cases admitted from home 
(17 (IQR: 11–34) days) compared with cases already 
in hospital (1 (IQR: 0–7) days; p=0.0001). The most 
common features at onset of illness were poor feeding 
(n=44, 65%), lethargy (n=30, 45%) and fever (tempera-
ture ≥38°C) (n=30, 44%). The majority of symptoms 
reported by parents appeared at the onset of infection 
(figure 2A) and these symptoms persisted, with very few 
new symptoms appearing over the subsequent 24 hours 
(figure 2B). However, there were small but significant 
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Table 2B Basic demographics of all infants
Parameter Value
Male 52 (54%)
Term (≥37 weeks) 74 (76%) 
Preterm (<37 weeks) 23 (24%) 
  32–36 14 (14%)
  28–31 5 (5%)
  <28 4 (4%)
Birth order
  Singleton 88 (91%)
  Twins 9 (9%)
Age distribution
  Early onset: 0–6 days 30 (31%)
  Late onset: 7–28 days 44 (45%)
   29–89 days 23 (24%) 
Route of admission
  Home 66 (68%)
  Inpatient 31 (32%) 
Ethnicity
  White 81(84%)
  Asian 6 (6%)
  Black 4 (4%)
  Unknown 6 (6%)
Region of England
  North of England 26 (26%)
  Midlands and East of England 18 (19%)
  London and integrated regions 13 (13%)
  South of England 39 (41%)
Infants mode of feeding at diagnosis
  Breast feeding 32 (38%)
  Mixed feeding 13 (20%) 
  Bottle feeding 32 (33%)
 Bacteria
 Identified from Cerebrospinal fluid only 23 (24%)
  Identified from cerebrospinal fluid and blood 40 (41%)
  Identified from blood only 34 (35%)
Group B streptococci 65 (63%)
Escherichia coli 11 (11%)
Listeria monocytogenes 4 (4%)
Neisseria meningitidis 4 (4%) 
Other Gram-negative bacteria* 10 (10%)
Other Gram-positive bacteria† 5 (5%)
Alive 96
Dead (after 28 hours in PICU after developing 
meningitis in the 4th week of life)
1
*Pseudomonas spp 3, Klebsiella spp 2, Salmonella spp 2, 
Citrobacter 1, Pasteurella spp 1, Haemophilus influenzae 1.
†Streptococcus pneumoniae 2, Streptococcus bovis 2 and 
α-haemolytic streptococcus 1.
differences in the proportion of infants with more specific 
symptoms at hospital admission compared with the onset 
of the illness: irritability (p=0.036), abnormal breathing 
(p=0.023) and abnormal movement/seizures (p=0.024) 
(figure 2C).
Twenty parents (30%) took their infants straight to the 
hospital: the Accident and Emergency (A&E) department 
(n=15, 22.5%) or the urgent care centre (n=5, 7.5%). 
The other parents (n=46, 70%) sought help by phoning 
the GP (n=21, 32%), calling the 24-hour NHS direct tele-
phone service (n=15, 23%) or contacting the community 
midwife (n=10, 15%); of these, 13 (28%) were advised to 
stay at home.
The median time from onset of first features to first 
help was 5.0 hours (IQR: 2.0–12.0). The time to first help 
was not associated with early-onset or late-onset disease, 
gestation at birth, presence of fever or seizure, region of 
the country, type of housing or level of maternal academic 
qualifications. The majority of parents (47/62, 76%) 
presented to hospital within 24 hours of onset of symp-
toms. Thirteen of 15 (93%) infants who were presented 
after 24 hours had fever (n=8) or seizures (n=4) or both 
(n=1) at the time they presented to hospital. Eight of the 
15 (53%) had attended their GP surgery before going to 
hospital; of these three were reviewed at the A&E/walk-in 
centre and sent home and two were initially seen by a 
community midwife (all five infants were seen <24 hours 
from onset). The remaining 7/15 (47%) infants were 
brought to hospital by their parents more than 24 hours 
from the onset of symptoms.
Overall, 20/66 (30%) infants were assessed to have 
received inappropriate prehospital management. 
Twelve infants with fever warranted further investiga-
tion according to the NICE guidelines and, in a further 
eight cases, there was a delay in seeking help despite the 
presence of worrying clinical features. Examples of inap-
propriate advice given to parents included being told that 
their child’s fever was due to a change in milk formula, or 
to an umbilical hernia, or where prune juice was recom-
mended for fever and irritability.
A&e management
Around half of the infants (n=36, 55%) were triaged in 
A&E during normal working hours. The median time 
from triage to receipt of the first antibiotic dose was 
2.0 hours (IQR: 1.0–3.3; >1 hour in 43 infants, 73%), but 
was significantly shorter in infants with fever or seizures at 
presentation than those without these features (1.7 (IQR: 
1.0–3.0) vs 4.2 (IQR: 1.8–6.3) hours, p=0.02). There was 
no significant difference in median time from triage to 
first antibiotic dose in infants, by early-onset or late-onset 
disease, region of the country, time of day at presentation 
or whether a fluid bolus was given. The median time from 
onset to GP visit, hospital attendance and first dose of anti-
biotics varied by route taken before admission (table 3). 
Onset to antibiotics time was significantly longer in those 
who were first seen by the GP.
group.bmj.com on September 5, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
 5Okike IO, et al. BMJ Open 2017;7:e015700. doi:10.1136/bmjopen-2016-015700
Open Access
Table 3 Median time in hours (IQR) from onset to general practitioner (GP), hospital visit and first dose of antibiotics by route 
taken prior to hospital admission
Category Onset to GP Onset to hospital visit
Onset to first dose of 
antibiotics
Infants who went from home direct to hospital Not applicable 5.7 hours (2–8.4) 8 hours (4.8–13.5)
Infants who went from home to hospital via GP 10.5 hours (3-33) 11 hours (5.2–17) 13 hours (6.8–25)
Infants who went to hospital via GP, were sent 
home and went to hospital a second time
9 hours (3.5–48) 52 hours (36-96) 57.5 hours (38–98.2)
p Value 0.8 0.0001 0.0001
Figure 2 (A) Time (hours) at which parents first noticed a specific clinical feature. (B) Number of features present at each hour 
as reported by parents. (C) Clinical features present at onset and time of admission.
Overall, 26 (39%) infants had a poor outcome in 
terms of death (one case) or neurological complica-
tion (25, 38%). These included motor disorder or 
developmental delay (n=12, 18%), seizures (n=7, 11%), 
hydrocephalus (n=5, 8%), hearing loss (n=5, 8%), cere-
bral infarct or ischaemia on MRI (n=3, 5%) or visual 
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Figure 3 (A) Time (hours) at which parents first noticed a specific clinical feature (inpatient cases). (B) Number of features 
present at each hour as reported by parents (inpatient cases). (C) Clinical features present at onset and time of admission 
(inpatient cases).
deficits (n=3, 5%). The median time in hours (IQR) 
from onset of illness to first help in infants with poor 
outcomes was longer than in those who recovered 
without sequelae (6.25 (IQR: 1–24) hours vs 4.75 (IQR: 
2–10) hours, p=0.8), but this was not statistically signifi-
cant. The rate of poor outcome was also not statistically 
different between the 15 infants who were presented to 
hospital >24 hours after onset of symptoms and those 
who were presented <24 hours (8/15 (53%) vs 18/47 
(38%); p=0.3). The interval between triage to first anti-
biotic dose was also not associated with poor outcome.
A number of predefined, potential explanatory factors 
(age, gender, time from onset to first help, delay in 
antibiotics, prehospital inappropriate advice, inappro-
priate empiric antibiotics, presence of fever, presence of 
seizures) were explored in univariate and multivariate 
analyses to identify risk factors for poor outcome; only 
the presence of seizures at presentation (OR, 7.9; 95% CI 
2.3 to 207.0) was found to be an independent risk factor 
(see online supplementary table 1).
Inpatient infants (n=31)
As with those infants presenting from home, parents of 
inpatient infants at the time of diagnosis reported that the 
majority of symptoms were all present at the onset of the 
illness (figure 3A) and remained present until diagnosis, 
with only a few new symptoms appearing during the course 
of the illness (figure 3B). The only significant difference 
between symptoms at onset and those at diagnosis was the 
proportion with breathing difficulty (p<0.001) (figure 3C).
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Table 4 Comparison of infants admitted from home and infants in hospital at the time of diagnosis
Variable All cases Home (n=66) Inpatient (n=31) p Value
Median age at disease (days) 14 (3–25) 17 (11–34) 1 (0–7) 0.0001
Early onset (<7 days) 30 (31%) 8 (12%) 22 (71%) <0.0001
Male 52 (54%) 34 (52%) 18 (58%) 0.5
Prematurity 23 (24%) 8 (12%) 15 (48%) <0.0001
Out-of-hours presentation 47 (48%) 30 (45%) 17 (55%) 0.4
Fever on presentation 48 (51%) 40 (61%) 8 (26%) 0.001
Seizure at presentation 33 (34%) 21 (32%) 12 (39%) 0.5
Received fluid bolus at presentation 53 (55%) 36 (55%) 17 (55%) 0.7
Antibiotics delay (hours) 2 (1.3–4) 2 (1–3.3) 2.6 (1.3–9.8) 0.09
LP done post first dose of antibiotics 57 (59%) 30 (45%) 27 (87%) <0.0001
Antibiotics to LP time >24 hours 33 (59%) 14 (47%) 19 (70%) 0.07
Median time to LP and no bacteria in CSF (hours) 46 (24–92.5) 24 (15.2–52.8) 65 (44–100.8) 0.017
Median time to LP and bacteria in CSF (hours) 7.3 (1.5–2.4) 3 (1–24) 9.5 (2–24) 0.3
Empiric antibiotics not in conformity with national guidelines 52 (54%) 35 (53%) 17 (55%) 0.9
Discharge to first OPD review (months) 2.5 (2.0–3.5) 2.5 (2.0–4.0) 2.5 (2.0–2.5) 0.6
Discharge from follow-up age <12 months 13 (14%) 12/65 (18%) 1/31 (3%) 0.03
Discharge from follow-up age <24 months 31 (32%) 26/65 (40%) 5/31 (16%) 0.02
Hearing test performed in survivors* 74 (77%) 53/65 (82%) 21/31 (68%) 0.1
Neurological complications 40 (42%) 26/65 (40%) 14/31 (45%) 0.6
Discharge to audiology test (days) 25 (0–32) 24 (10–42) 26 (0–28) 0.2
Informed of meningitis support charities 13/97 (13%) 11/66 (17%) 2/31 (6%) 0.2
*There were 22 survivors without report of hearing test. 12 (13%) had no record of hearing test at review, 5 (5%) were transferred to another 
hospital where data were not available, and 4 (12%) had the review <1 month after discharge and 1 (1%) missed two appointments.
CSF, cerebrospinal fluid; LP, lumbar puncture; OPD, outpatient department.
Two-thirds of infants (21/31, 68%) had onset of 
symptoms within 72 hours of birth, and were therefore 
assessed against the NICE early-onset antibiotic guide-
lines. According to these guidelines, the maternal ‘red 
flags’ (mainly chorioamnionitis/maternal sepsis in 5), 
baby ‘red flags’ (respiratory distress after 4 hours of age 
in 9, shock in 4, seizures in 2 and need for ventilation at 
term in 1) or both were present in 5/21 (24%), 15/21 
(71%) and 17/21 (81%), respectively. At the time of diag-
nosis, 17/31 (55%) of these infants received a fluid bolus, 
12/31 (39%) had seizures and 8/31 (26%) had a fever.
The median time from onset of symptoms to first antibi-
otic dose was 2.6 hours (IQR: 1.3–8.5), with 74% (23/31) 
receiving their first dose >1 hour after onset of symptoms 
and four infants (13%) receiving the first dose >24 hours 
after onset.
Outcomes among inpatient infants
Overall, 12/31 (39%) of infants had a serious neuro-
logical complication at hospital discharge, including 
developmental delay or motor disorder (n=9, 29%), 
abnormal hearing (n=5, 16%), hydrocephalus/ventri-
culo-peritoneal (VP) shunt (n=5, 16%), seizures (n=2, 
6%) and abnormal MRI: cortical grey and white matter 
injury (n=1, 3%) and two infants were treated for cerebral 
abscesses. No significant risk factors for poor outcomes 
were identified in either the univariate or multivariate 
analysis (see online supplementary table 1).
home versus inpatient infants
The main differences between infants admitted from 
home and inpatient cases were age, presence of fever 
on presentation, timing of lumbar puncture and time to 
discharge from outpatient follow-up (table 4).
empiric antibiotics
The empiric antibiotics used in 35/66 (53%) and 17/31 
(55%) of infants admitted from home and inpatient cases, 
respectively, were not in conformity with the appropriate 
NICE guidelines (see online supplementary table 2).
Follow-up and hearing tests after discharge
The median time to first outpatient follow-up was 2.5 
months (IQR: 2–3.5) and was not different among infants 
admitted from home and inpatient cases (table 4). 
However, infants from home were more likely to be 
discharged from follow-up before 2 years of age. A hearing 
test was performed in 74/96 (77%) survivors (table 4). 
The median time from discharge to hearing test was 25 
days (IQR: 0–32), with 30 (41%) and 14 (19%) infants 
having the hearing test ≥4 and ≥6 weeks after hospital 
discharge, respectively.
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DISCuSSIOn
This is the first study to assess in detail the course of the 
illness in young infants with bacterial meningitis and the 
early healthcare they receive. Parental reporting of the 
early features of bacterial meningitis is a unique aspect 
of this study. We have shown that in infants with bacterial 
meningitis, most of the symptoms and signs as reported 
by parents are present from the onset of the illness and 
there is little progression, with no or few additional 
symptoms developing as the illness progresses. Notably, 
up to 40% of infants did not develop fever at any time 
during their illness. In keeping with previous studies, only 
seizures at presentation were significantly associated with 
a poor outcome.2
The course of bacterial meningitis in young infants 
appears to be different from that of children with meningo-
coccal meningitis. With a similar study design, Thompson 
and colleagues demonstrated that meningococcal disease 
progresses in a stereotypical manner in all children, with 
a prodromal phase, early sepsis phase and meningism 
only as a late feature.6 In terms of the healthcare-seeking 
behaviour for those infants admitted from home, 70% 
of parents had sought medical help prior to A&E atten-
dance. Of concern, a significant proportion had received 
inappropriate advice, suggesting that further training of 
front-line healthcare staff in recognising serious illness in 
children is required.18 On the other hand, many of the 
parents who presented to hospital more than 24 hours 
after the initial healthcare contact are most likely because 
their child’s condition deteriorated, thus highlighting 
the importance of providing appropriate safety-netting 
advice to parents if they are advised to return home.
On admission to hospital, the median time from 
triage to first antibiotic dose was 2 hours, lower than that 
recently reported for childhood septicaemia (3 hours)19 
but higher than the recommended threshold of 1 hour.20 
We identified a number of reasons for this delay, 
including uncertainty in recognition (especially in those 
with non-specific presentations), over-reliance on the 
presence of fever, waiting for urine samples before giving 
antibiotics and waiting for handover between shifts. 
Presentation in-hours or out-of-hours did not influence 
time to first antibiotic, which is reassuring given that half 
of infants were presented out of hours. That infants with 
fever or seizure received antibiotics more quickly than 
those without these features suggests that these delays 
can potentially be avoided. Miner et al showed that delay 
to antibiotics time is significantly shorter in patients who 
received it in the emergency department.21 With appro-
priate education strategies, it is therefore possible to 
significantly improve antibiotic delivery time for infants.22
Most inpatient infants developed meningitis within 
72 hours of birth, suggesting vertical transmission of 
infection. The recent NICE guidelines for early-onset 
antibiotics provide guidance on maternal, birth and 
infant risk factors that should lead to specific and timely 
antibiotic therapy.17 Notably, 80% of infants had such risk 
factors, suggesting this to be a useful tool. However the 
time to antibiotic administration and the choice of anti-
biotic were still very variable. Adult studies from USA and 
France reported low compliance to established guide-
lines.23 24
There is still a need to reinforce to clinicians the 
importance of performing a timely hearing test in 
infants with bacterial meningitis. There is no record 
of such a test in 23% of cases, and even when done it 
was ≥4 weeks in 40%. National guidelines emphasise the 
need for early diagnosis of deafness to allow early inter-
ventions such as cochlear implantation.16 Follow-up 
of infants with bacterial meningitis is also believed to 
be important as it should allow early identification of 
those with neurodevelopmental impairment (likely to 
be around 50% of survivors)4 25 and timely intervention 
and support.16
SuMMARy
The impact of bacterial meningitis on young infants and 
their families is significant. Case fatality rates and severe 
complications among survivors remain unacceptably high, 
at least partly due to delayed recognition and manage-
ment. Unlike children with meningococcal disease, for 
example, we were unable to identify any distinctive features 
at disease onset or of symptom progression that might aid 
earlier recognition or trigger earlier healthcare presen-
tation. We propose a targeted campaign for education of 
new parents, primary care health workers (including tele-
phone advice providers) and hospital doctors regarding 
the non-specific features, the lack of progression of clin-
ical features at least in the first 24 hours and the lack of 
fever in young infants with bacterial meningitis. There is 
also need to explore ways of harmonising clinical practice 
with evidence-based management algorithms, including 
timely investigation and administration of appropriate 
antibiotics and adequate follow-up of infants with bacte-
rial meningitis.
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